ECARX Holdings (ECX) Research & Development (2021 - 2026)

ECARX Holdings (ECX) has reported Research & Development for 6 consecutive years, with -$29.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Research & Development rose 13.91% year-over-year to -$29.1 million; the trailing twelve-month figure through Jun 2026 stood at -$107.6 million (up 34.35% YoY), and the FY2025 full-year result was -$123.3 million, up 29.47% from the prior year.
• Research & Development retreated to -$29.1 million in Q2 2026 per ECX's latest filing, from -$23.5 million in the prior quarter.
• Across five years, Research & Development topped out at -$23.5 million in Q1 2026 and bottomed at -$67.3 million in Q4 2022.
• Historically, Research & Development has averaged -$39.6 million across 5 years, with a median of -$35.9 million in 2024.
• The sharpest annual moves came in 2023 and 2025: Research & Development slumped 60.76% in 2023, then jumped 45.82% in 2025.
• Over 5 years, Research & Development stood at -$67.3 million in 2022, then gained by 0.89% to -$66.7 million in 2023, then climbed by 28.34% to -$47.8 million in 2024, then jumped by 39.12% to -$29.1 million in 2025, then changed by 0.0% to -$29.1 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered -$29.1 million, -$23.5 million, and -$29.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.